FDA — authorised 10 June 2024
- Application: NDA218860
- Marketing authorisation holder: IPSEN
- Local brand name: IQIRVO
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Iqirvo in United States
FDA authorised Iqirvo on 10 June 2024
Marketing authorisations
FDA
- Marketing authorisation holder: IPSEN
- Status: approved
Iqirvo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Iqirvo approved in United States?
Yes. FDA authorised it on 10 June 2024; FDA has authorised it.
Who is the marketing authorisation holder for Iqirvo in United States?
IPSEN holds the US marketing authorisation.